We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




EuroMedLab 2025 Showcases Latest Technologies and Innovations in Laboratory Medicine

By LabMedica International staff writers
Posted on 20 May 2025

The 26th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab 2025), hosted by the Royal Belgian Society of Laboratory Medicine (RBSLM, Verviers, Belgium), in collaboration with MZ Events (Milan, Italy), is taking place from May 18 to 22, 2025 in Brussels, Belgium. More...

EuroMedLab is the biggest European congress in the field of clinical chemistry and laboratory medicine, with more than 5,000 delegates and 4,000 visitors from over 100 countries. This prestigious joint event is organized every two years by International Federation of Clinical Chemistry and Laboratory Medicine (IFCC, Milano, Italy) and European Federation of Clinical Chemistry and Laboratory Medicine (EFLM, Milano, Italy). EuroMedLab 2025 serves as a platform to showcase the latest technologies and innovations in laboratory medicine, exploring their potential applications in healthcare. This gathering facilitates the exchange of ideas and foster collaboration among researchers and clinicians, with the ultimate objective of advancing patient care and outcomes.

The Scientific Program Committee has curated an exceptional, thought-provoking, and inspirational multidisciplinary program that encompasses a wide array of significant themes, including fundamental concepts, advanced diagnostics, and cutting-edge techniques utilized in laboratory medicine. Esteemed international speakers and key opinion leaders are presenting on a myriad of topics spanning healthcare, recent diagnostic technologies, scientific breakthroughs, and the challenges in laboratory medicine.

The congress also features plenary lectures, symposia, interactive roundtables, educational workshops, poster sessions, and a major industry exhibition. At the educational industry workshops, attendees gain practical insights into the latest diagnostic platforms, analytical solutions, and clinical applications directly from leading companies. The IVD Sector is hosting an extensive exhibition, offering attendees a prime opportunity to explore recent technological advancements, products, and services designed to enhance laboratory operations. The generous exhibition floor at the event features 111 booths where 115 diagnostic industries are displaying their latest products and innovative solutions. These practical solutions are tailored to meet the specific needs of clinical laboratories, ensuring attendees to gain valuable insights and access to cutting-edge tools in the field.

EuroMedLab 2025 is also hosting several satellite events, including the 4th Young Scientists Forum, which offers tailored sessions aimed at empowering and inspiring the next generation of leaders in laboratory medicine. This year, EuroMedLab has set new records with an unprecedented 2,959 scientific abstracts submitted by researchers and professionals from around the globe. Additionally, a record number of IVD industry companies and IFCC Corporate Members are participating in the exhibition—indicating that this could be the best-attended and most impactful EuroMedLab Congress to date.

Related Links:
IFCC
EFLM
RBSLM 
MZ Events 


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA
New
Gold Member
Latex Test
SLE-Latex Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.